AbCellera Biologics is a biotechnology business based in the US. AbCellera Biologics stocks (ABCL.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $23.53 – a decrease of 13.99% over the previous week. AbCellera Biologics employs 360 staff and has a trailing 12-month revenue of around $443.8 million.
How to buy shares in AbCellera Biologics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ABCL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in AbCellera Biologics?
- AbCellera Biologics shares summary
- Compare share dealing platforms
- Is AbCellera Biologics stock a buy or sell?
- AbCellera Biologics performance over time
- Are AbCellera Biologics shares over-valued?
- AbCellera Biologics's financials
- Does AbCellera Biologics pay a dividend?
- Other common questions
AbCellera Biologics stock price (NASDAQ:ABCL)Use our graph to track the performance of ABCL stocks over time.
AbCellera Biologics shares at a glance
|Latest market close||$7.81|
|52-week range||$7.42 - $55.22|
|50-day moving average||$13.62|
|200-day moving average||$19.24|
|Wall St. target price||$38.88|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.64|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy AbCellera Biologics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
AbCellera Biologics price performance over time
|1 week (2022-01-21)||-9.61%|
|1 month (2021-12-28)||-43.03%|
|3 months (2021-10-28)||-50.94%|
|6 months (2021-07-28)||-51.43%|
|1 year (2021-01-28)||-84.83%|
|2 years (2020-01-24)||N/A|
|3 years (2019-01-24)||N/A|
|5 years (2017-01-24)||N/A|
Is AbCellera Biologics under- or over-valued?
Valuing AbCellera Biologics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AbCellera Biologics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AbCellera Biologics's P/E ratio
AbCellera Biologics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, AbCellera Biologics shares trade at around 13x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
AbCellera Biologics's EBITDA
AbCellera Biologics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $298.5 million.
The EBITDA is a measure of a AbCellera Biologics's overall financial performance and is widely used to measure a its profitability.
AbCellera Biologics financials
|Revenue TTM||$443.8 million|
|Operating margin TTM||64.34%|
|Gross profit TTM||$176.6 million|
|Return on assets TTM||27.14%|
|Return on equity TTM||40.38%|
|Market capitalisation||$2.4 billion|
TTM: trailing 12 months
AbCellera Biologics share dividends
We're not expecting AbCellera Biologics to pay a dividend over the next 12 months.
AbCellera Biologics overview
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are either completed, in progress, or under contract. It has a discovery partnership agreement with Eli Lilly and Company. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.
AbCellera Biologics in the news
AbCellera to Report Full Year 2021 Financial Results on February 24, 2022
Boasting A 22% Return On Equity, Is AbCellera Biologics Inc. (NASDAQ:ABCL) A Top Quality Stock?
Netflix shares fall near pre-pandemic level as investors fear slowing subscriber growth, competition
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Nauticus Robotics, Inc. (KITT) stock in Canada when it goes public
Everything we know about the Nauticus Robotics, Inc. IPO, plus information on how to buy in.
What is Mogo and how can you access its new trading platform, MogoTrade? Find out in our review.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Bitcoin Private (BTCP) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Bitcoin Private, lists some exchanges where you can get it and provides daily price data on BTCP.
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
Ask an Expert
You must be logged in to post a comment.